Columbia Partners Investment Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$1.02M Sell
49,907
-129,813
-72% -$4.06M 0.4% 83
2018
Q3
$6.62M Sell
179,720
-7,609
-4% -$332K 1.69% 13
2018
Q2
$9.41M Sell
187,329
-15,410
-8% -$679K 2.69% 5
2018
Q1
$7.4M Hold
202,739
0.94% 20
2017
Q4
$5.74M Sell
202,739
-27,379
-12% -$646K 0.76% 34
2017
Q3
$4.45M Sell
230,118
-56,028
-20% -$941K 0.59% 46
2017
Q2
$4.79M Buy
286,146
+30,176
+12% +$407K 0.61% 45
2017
Q1
$2.67M Sell
255,970
-104,954
-29% -$1.07M 0.34% 90
2016
Q4
$3.25M Buy
360,924
+250,403
+227% +$2.16M 0.29% 119
2016
Q3
$998K Buy
+110,521
New +$899K 0.08% 237

Other funds holding AXGN

Columbia Partners Investment Management's AXGN Position: Q4 2018 in Review

Columbia Partners Investment Management reduced its Axogen (AXGN) stake by 72% in Q4 2018, selling an estimated $4.06M and leaving 49,907 shares worth $1.02M. The position accounts for 0.4% of the portfolio, ranked #83.

Columbia Partners Investment Management first reported a position in AXGN in Q3 2016 and has held it in 10 quarters since. The position peaked at $9.41M in Q2 2018. 146 funds tracked by Wall St. Rank hold AXGN as of Q4 2018.

  • Columbia Partners Investment Management held 49,907 shares of Axogen worth $1.02M as of Q4 2018.
  • Columbia Partners Investment Management sold 129,813 Axogen shares in Q4 2018, an estimated $4.06M.
  • Axogen made up 0.4% of Columbia Partners Investment Management's portfolio in Q4 2018, its #83 holding.
  • Columbia Partners Investment Management first reported a position in Axogen in Q3 2016 and has held it in 10 quarters since.
  • Columbia Partners Investment Management's Axogen position peaked at $9.41M in Q2 2018.
  • 146 funds tracked by Wall St. Rank held Axogen as of Q4 2018.

Based on Columbia Partners Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.